{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:02:34Z","timestamp":1789718554656,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.pan.2024.09.018","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T16:03:25Z","timestamp":1727107405000},"page":"1049-1056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and spectrum of germline pathogenic variants in cancer susceptibility genes among mexican patients with exocrine pancreatic cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-1331","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Rodr\u00edguez-Olivares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1107-0771","authenticated-orcid":false,"given":"Tamara N.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Jeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"De-La-Mora-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8859-9115","authenticated-orcid":false,"given":"Isaac","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-1817","authenticated-orcid":false,"given":"Yanin","family":"Ch\u00e1varri-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2024.09.018_bib1","series-title":"Global cancer observatory: cancer Today 2024","author":"Ferlay","year":"2024"},{"key":"10.1016\/j.pan.2024.09.018_bib2","article-title":"Hereditary pancreatic cancer","volume":"58\u201359","author":"Klatte","year":"2022","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.pan.2024.09.018_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3322\/caac.20128","article-title":"Genetics, genomics and cancer risk assessment: state of the art and future directions in the era of personalized medicine","volume":"61","author":"Weitzel","year":"2011","journal-title":"CA A Cancer J Clin"},{"issue":"2","key":"10.1016\/j.pan.2024.09.018_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10689-017-0019-5","article-title":"The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes","volume":"17","author":"Slavin","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.pan.2024.09.018_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/89.6.442","article-title":"Hereditary pancreatitis and the risk of pancreatic cancer. International hereditary pancreatitis study group","volume":"89","author":"Lowenfels","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pan.2024.09.018_bib6","year":"2023","journal-title":"To view the most recent and complete version of the guideline, go online to NCCN.org"},{"issue":"2","key":"10.1016\/j.pan.2024.09.018_bib7","first-page":"94","article-title":"Genetic cancer risk assessment for breast cancer in Latin America","volume":"69","author":"Chavarri-Guerra","year":"2017","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.pan.2024.09.018_bib8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/GO.20.00587","article-title":"Development and pilot implementation of the genomic risk assessment for cancer implementation and sustainment (GRACIAS) intervention in Mexico","volume":"7","author":"Blazer","year":"2021","journal-title":"JCO global oncology"},{"issue":"5","key":"10.1016\/j.pan.2024.09.018_bib9","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/jgs.15937","article-title":"The burden of breast cancer predisposition variants across the age spectrum among 10 000 patients","volume":"67","author":"Chavarri-Guerra","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"107","key":"10.1016\/j.pan.2024.09.018_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41523-021-00317-6","article-title":"Genetic Epidemiology of BRCA1- and BRCA2-associated cancer across Latin America","volume":"7","author":"Herzog","year":"2021","journal-title":"NPJ-Breast Cancer"},{"issue":"5","key":"10.1016\/j.pan.2024.09.018_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clgc.2023.05.012","article-title":"Germline DNA repair genes pathogenic variants among Mexican patients with prostate cancer","volume":"21","author":"Chavarri-Guerra","year":"2023","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.pan.2024.09.018_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Committee, standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"16","key":"10.1016\/j.pan.2024.09.018_bib13","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/cncr.32083","article-title":"Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer","volume":"125","author":"Weitzel","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.pan.2024.09.018_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.48721","article-title":"Prevalence of germline sequence variations among patients with pancreatic cancer in China","volume":"5","author":"Yin","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.pan.2024.09.018_bib15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jnci\/djy024","article-title":"Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms","volume":"110","author":"Lowery","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.pan.2024.09.018_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s10020-023-00600-1","article-title":"Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study","volume":"29","author":"Tavano","year":"2023","journal-title":"Mol Med"},{"issue":"6","key":"10.1016\/j.pan.2024.09.018_bib17","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/cancers15061852","article-title":"Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer or suspected related hereditary syndromes: historical prospective analysis","volume":"15","author":"Dal Buono","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.pan.2024.09.018_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/gim.2017.85","article-title":"Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history","volume":"20","author":"Chaffee","year":"2018","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.pan.2024.09.018_bib19","first-page":"1105","article-title":"Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer","volume":"52","author":"Terashima","year":"2022","journal-title":"Jpn J Clin Oncol"},{"issue":"33","key":"10.1016\/j.pan.2024.09.018_bib20","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1200\/JCO.23.00561","article-title":"Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma","volume":"41","author":"Mandelker","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.pan.2024.09.018_bib21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jamaoncol.2021.3701","article-title":"Risk of pancreatic cancer among individuals with pathogenic variants in the ATM gene","volume":"7","author":"Hsu","year":"2021","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.pan.2024.09.018_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa121","article-title":"Clinical characteristics of patients with pancreatic cancer and pathogenic ATM alterations","volume":"5","author":"Hannan","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.pan.2024.09.018_bib23","series-title":"CDKN2A\". Genetics home reference","year":"2023"},{"issue":"20","key":"10.1016\/j.pan.2024.09.018_bib24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jnci\/dji312","article-title":"Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample","volume":"97","author":"Begg","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.pan.2024.09.018_bib25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.pan.2024.09.018_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study","volume":"17","author":"Zhen","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.pan.2024.09.018_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/jmedgenet-2011-100281","article-title":"CDKN2A is the main susceptibility gene in Italian pancreatic cancer families","volume":"49","author":"Ghiorzo","year":"2012","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pan.2024.09.018_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10689-021-00284-8","article-title":"Discrepant CDKN2A c.146 T > C variant: a clinical experience. Collaborative group of the americas on inherited gastrointestinal cancers (CGA-IGC) annual virtual meeting, november 13\u201315, 2021","volume":"21","author":"Gemmell","year":"2022","journal-title":"Fam Cancer"},{"key":"10.1016\/j.pan.2024.09.018_bib29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","article-title":"A\u00a0structural variation reference for medical and population genetics","volume":"581","author":"Collins","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pan.2024.09.018_bib30","first-page":"489","volume":"vol. 21","author":"van den Berg","year":"2022"},{"issue":"28","key":"10.1016\/j.pan.2024.09.018_bib31","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1200\/JCO.22.00194","article-title":"Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up","volume":"40","author":"Klatte","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.pan.2024.09.018_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance Olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.pan.2024.09.018_bib33","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1200\/JCO.19.01890","article-title":"Geographic and ethnic heterogeneity of germline BRCA1 or BRCA2 mutation prevalence among patients with metastatic pancreatic cancer screened for entry into the POLO trial","volume":"38","author":"Golan","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.pan.2024.09.018_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21149\/12704","article-title":"Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancer","volume":"64","author":"Chavarri-Guerra","year":"2022","journal-title":"Salud Publica Mex"},{"issue":"2","key":"10.1016\/j.pan.2024.09.018_bib35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tranon.2019.11.003","article-title":"Clinical evaluation of BRCA1\/2 mutation in Mexican ovarian cancer patients","volume":"13","author":"Gallardo-Rinc\u00f3n","year":"2020","journal-title":"Transl Oncol"},{"issue":"7","key":"10.1016\/j.pan.2024.09.018_bib36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families","volume":"38","author":"Yang","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.pan.2024.09.018_bib37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaoncol.2021.0006","article-title":"Olaparib monotherapy for previously treated pancreatic cancer with DNA damage repair genetic alterations other than germline BRCA variants: findings from 2 phase 2 nonrandomized clinical trials","volume":"7","author":"Javle","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.pan.2024.09.018_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12885-019-5312-2","article-title":"Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population","volume":"19","author":"Gallardo-Alvarado","year":"2019","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.pan.2024.09.018_bib39","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","article-title":"Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study","volume":"22","author":"De Andrade","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.pan.2024.09.018_bib40","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","article-title":"Differences in cancer phenotypes among frequent CHEK2 variants and implications for clinical care-checking CHEK2","volume":"8","author":"Bychkovsky","year":"2022","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.pan.2024.09.018_bib41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10689-021-00285-7","article-title":"Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer","volume":"21","author":"Thompson","year":"2022","journal-title":"Fam Cancer"},{"issue":"10","key":"10.1016\/j.pan.2024.09.018_bib42","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","article-title":"Cancer susceptibility gene mutations in individuals with colorectal cancer","volume":"35","author":"Yurgelun","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.pan.2024.09.018_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0945","article-title":"Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020","volume":"4","author":"Landry","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.pan.2024.09.018_bib44","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/1078-0432.CCR-17-3099","article-title":"Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: challenges and recommendations","volume":"24","author":"Hu","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.pan.2024.09.018_bib45","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamasurg.2017.2631","article-title":"Clinical and genetic implications of DNA mismatch repair deficiency in patients with pancreatic ductal adenocarcinoma","volume":"152","author":"Cloyd","year":"2017","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1016\/j.pan.2024.09.018_bib46","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3390\/cancers16112111","article-title":"Mutations in mismatch repair genes and microsatellite instability status in pancreatic cancer","volume":"16","author":"Emelyanova","year":"2024","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.pan.2024.09.018_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa054","article-title":"Universal screening of gastrointestinal malignancies for mismatch repair deficiency at stanford","volume":"4","author":"Abrha","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.pan.2024.09.018_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.humpath.2022.12.016","article-title":"Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type","volume":"135","author":"Matsubayashi","year":"2023","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.pan.2024.09.018_bib49","first-page":"942","article-title":"Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer","volume":"37","author":"Latham","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"10.1016\/j.pan.2024.09.018_bib50","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.2009.1529","article-title":"Risk of pancreatic cancer in families with Lynch syndrome","volume":"302","author":"Kastrinos","year":"2009","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.pan.2024.09.018_bib51","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.pan.2024.09.018_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.286.2.169","article-title":"Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis","volume":"286","author":"Lowenfels","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.pan.2024.09.018_bib53","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/ijc.31257","article-title":"The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers","volume":"142","author":"Ko","year":"2018","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.pan.2024.09.018_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.pan.2024.09.018_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jnci\/djy090","article-title":"Pancreatic cancer following incident diabetes in african Americans and Latinos: the multiethnic cohort","volume":"111","author":"Setiawan","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.pan.2024.09.018_bib56","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic cancer following diabetes: a population-based study","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.pan.2024.09.018_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4945","article-title":"Association of glycated hemoglobin levels with risk of pancreatic cancer","volume":"3","author":"Wu","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.pan.2024.09.018_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.pan.2024.09.018_bib59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/oncolo\/oyad044","article-title":"Adherence to NCCN genetic testing guidelines in pancreatic cancer and impact on treatment","volume":"28","author":"Crowley","year":"2023","journal-title":"Oncol"},{"issue":"6","key":"10.1016\/j.pan.2024.09.018_bib60","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1007\/s40615-022-01486-1","article-title":"Health Disparities in presentation, treatment, genomic testing, and outcomes of pancreatic cancer in hispanic and non-hispanic patients","volume":"10","author":"Halder","year":"2023","journal-title":"J\u00a0Racial Ethn Health Disparities"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S142439032400749X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S142439032400749X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T15:36:07Z","timestamp":1731166567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S142439032400749X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S142439032400749X"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2024.09.018","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and spectrum of germline pathogenic variants in cancer susceptibility genes among mexican patients with exocrine pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2024.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}